Further studies showed that the adoptive transfer of autologous HER2-specific T-lymphocyte clones to a patient with metastatic HER2-overexpressing breast cancer prevented tumor cell dissemination to the bone marrow. Here, ERBB2 is linked to breast carcinoma.